The deal between the White House and Democrats would raise the debt ceiling for two years and permanently end the sequester.Politicsread more
"Whether it's this year or next year, the odds of another economic downturn are high — and growing," Warren says.Politicsread more
A group of gold miners stocks, "BAANG," are better plays than mega-cap FAANG names, according to John Roque, technical analyst at Wolfe Research.Marketsread more
A different oil pricing dynamic has been evolving with new supply calculations based on the U.S. as the world's largest producer.Market Insiderread more
Equifax will give consumers a range of options for monitoring their credit or making claims of fraud or data misuse, part of a $425 million restitution fund.Technologyread more
Trade tensions that could lead to layoffs and a pullback from consumers are at the center of the recession case.Economyread more
Microsoft and OpenAI announced a new partnership to build artificial general intelligence to tackle more complex tasks than current AI.Technologyread more
There's a reason the film industry doesn't measure the success of modern movies against those of the past — movie ticket inflation isn't an exact science.Entertainmentread more
A US judge presiding over multidistrict litigation alleging J&J's talc baby powder causes ovarian cancer starts hearing from experts Monday.Health and Scienceread more
Investors with $1 million or more in the market expect the pace of stock market gains to slow over the remainder of 2019. But these wealthy self-directed brokerage account...Investingread more
Air-conditioner maker Lennox International pointed to colder weather as a key reason for cutting guidance and underperforming in the second quarter.Marketsread more
After more than three years of bullishness, one pro at Morgan Stanley said he is balancing his market outlook for the second half of this year.
Morgan Stanley has a 12-month target of 2,050 for the S&P 500, said Adam Parker, U.S. equity strategist at Morgan Stanley. The index traded above 2,090 midday Wednesday.
"I don't think the earnings trajectory is going to accelerate much beyond kind of low-to-mid singles [digits] in the U.S.," Parker told CNBC's "Fast Money: Halftime Report " on Wednesday.
With bonds, financials, technology companies and biotech stocks all facing challenges, Parker said utilities have been working. The S&P 500 utilities sector has popped more than 24 percent in the past year, compared to a just-over 1 percent change in the overall S&P 500.
"I think there's something to be said, despite absolute valuations looking high, for continuing to own yielding instruments, which compared to government bonds are going to continue to look quite compelling," Parker said.
In contrast, Morgan Stanley recently got more cautious on financials, despite growth in shareholder return, limited currency exposure and compelling valuations, he said.
"It's just too hard to separate that sector interest rate environment," Parker said. "If the the 10-year is going to go the way of the bund and [Japanese government bond], it's hard for these stocks to .... really earn high returns. "
The Federal Reserve has held back on raising interest rates as international politics have impacted financial markets across the globe. Meanwhile, German bond yields dipped into negative territory last month, following Japan's February slide.
Even technology and biotechnology companies aren't the haven of growth that they used to be, Parker said. A fund that tracks Nasdaq's biotechnology companies has fallen nearly 29 percent over the past year as politicians took aim at high drug prices. At the same time, a fund that tracks technology companies is nearly flat over the past year, despite its reputation as a high-growth sector.
"That portion of the market has not regained its glory yet," Parker said.